// App-Quantinova.ai

582 : T-DM1 to induce response in central nervous system (CNS) metastases from Her2 +ve metastatic breast cancer (MBC).

Researchers

Presenter

  • Yamini McCABE

Principal Investigators

  • Andrew M. Wardley

  • Anne Caroline Armstrong

  • Sacha Jon Howell

Medical Centers

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • The Christie Hospital, Huddersfield, United Kingdom

  • Christie Hospital, Altrincham, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final